Market Overview:
The global biopharmaceutical lab equipment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biopharmaceuticals, technological advancements in lab equipment, and rising investments by pharmaceutical companies in R&D activities. Based on type, the global biopharmaceutical lab equipment market can be segmented into pretreatment type, reaction type, analysis & test type, and others. The pretreatment type segment is expected to account for the largest share of the global market in 2018 owing to its growing demand for downstream processing of biomolecules. By application, the research institutions segment is projected to account for the largest share of the global biopharmaceutical lab equipment market duringthe forecast period.
Product Definition:
Biopharmaceutical lab equipment is used to manufacture biopharmaceuticals, which are drugs made from biological sources. This type of drug is often used to treat diseases such as cancer, diabetes, and arthritis. The equipment is important because it allows manufacturers to create these life-saving drugs in a safe and controlled environment.
Pretreatment Type:
Pretreatment is a process in which the equipment used for biopharmaceutical manufacturing is cleaned and prepared before actual process of production. This helps to remove any unwanted substances that may affect the final product quality. Various types of pretreatment methods include desalting, rinsing, decolorizing, and degreasing among others.
Reaction Type:
A reaction type is a method used to convert one reactant into another. There are two major reaction types in biopharmaceutical labs, namely hydrolysis and oxidation. Hydrolysis can be performed by using hot water or aqueous sodium hydroxide solution; while oxidation can be done with the help of chromium (III) oxide or hydrogen peroxide.
Application Insights:
The research institutions segment dominated the global biopharmaceutical lab equipment market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to increasing government funding for R&D activities in various countries, such as U.S., China, India, Brazil etc. Furthermore, an increase in number of research projects pertaining to novel drug development is also anticipated to boost industry growth over the forecast period.
Pharmaceutical factories are anticipated to exhibit a higher CAGR of XX% from 2018 to 2030 owingto growing demand for biopharmaceutical products that require high-quality control throughout production and clinical stages of development & their associated services such as Quality Control Services (QCS), Consulting Services (CSS).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biopharmaceutical manufacturers, which use advanced technologies for drug discovery and development. Moreover, increasing R&D activities by various companies in this region is contributing towards growth of the regional market.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising investments by governments and private entities for research on target diseases such as cancer, diabetes, & arthritis that affect large population groups in this region. In addition, growing awareness about bio-based economy among people from government as well as from general public has led them to support life science research activities thereby driving regional market growth over forecast period.
Growth Factors:
- Increasing demand for biopharmaceuticals: The global biopharmaceutical market is expected to grow at a CAGR of 10.5% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about available treatments, and technological advancements in the field of biopharmaceuticals.
- Growing number of approvals for novel drugs: The number of new drug approvals has been on the rise in recent years, with the FDA approving 46 novel drugs in 2016 as against 23 in 2010. This trend is likely to continue over the next few years as well, driving demand for lab equipment used for R&D purposes.
- Rising investment in life sciences research: Governments and private investors are increasingly allocating funds towards life sciences research, with a view to developing new therapies and improving healthcare outcomes worldwide. This is likely to result in increased demand for lab equipment used for R&D purposes over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biopharmaceutical Lab Equipment Market Research Report
By Type
Pretreatment Type, Reaction Type, Analysis & Test Type, Others
By Application
Research Institutions, Pharmaceutical Factory
By Companies
GE Healthcare, Agilent Technologies, Waters, Danaher, Thermo Fisher Scientific, Bruker, Eppendorf, Millipore, Shimadzu, Brand GmbH, Telstar
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Biopharmaceutical Lab Equipment Market Report Segments:
The global Biopharmaceutical Lab Equipment market is segmented on the basis of:
Types
Pretreatment Type, Reaction Type, Analysis & Test Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institutions, Pharmaceutical Factory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Agilent Technologies
- Waters
- Danaher
- Thermo Fisher Scientific
- Bruker
- Eppendorf
- Millipore
- Shimadzu
- Brand GmbH
- Telstar
Highlights of The Biopharmaceutical Lab Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pretreatment Type
- Reaction Type
- Analysis & Test Type
- Others
- By Application:
- Research Institutions
- Pharmaceutical Factory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopharmaceutical Lab Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biopharmaceutical lab equipment is used to produce pharmaceuticals. This includes everything from small laboratory scales to large, expensive machines.
Some of the major players in the biopharmaceutical lab equipment market are GE Healthcare, Agilent Technologies, Waters, Danaher, Thermo Fisher Scientific, Bruker, Eppendorf, Millipore, Shimadzu, Brand GmbH, Telstar.
The biopharmaceutical lab equipment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopharmaceutical Lab Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biopharmaceutical Lab Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biopharmaceutical Lab Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biopharmaceutical Lab Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biopharmaceutical Lab Equipment Market Size & Forecast, 2018-2028
4.5.1 Biopharmaceutical Lab Equipment Market Size and Y-o-Y Growth
4.5.2 Biopharmaceutical Lab Equipment Market Absolute $ Opportunity
Chapter 5 Global Biopharmaceutical Lab Equipment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biopharmaceutical Lab Equipment Market Size Forecast by Type
5.2.1 Pretreatment Type
5.2.2 Reaction Type
5.2.3 Analysis & Test Type
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biopharmaceutical Lab Equipment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biopharmaceutical Lab Equipment Market Size Forecast by Applications
6.2.1 Research Institutions
6.2.2 Pharmaceutical Factory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biopharmaceutical Lab Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopharmaceutical Lab Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biopharmaceutical Lab Equipment Analysis and Forecast
9.1 Introduction
9.2 North America Biopharmaceutical Lab Equipment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biopharmaceutical Lab Equipment Market Size Forecast by Type
9.6.1 Pretreatment Type
9.6.2 Reaction Type
9.6.3 Analysis & Test Type
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biopharmaceutical Lab Equipment Market Size Forecast by Applications
9.10.1 Research Institutions
9.10.2 Pharmaceutical Factory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biopharmaceutical Lab Equipment Analysis and Forecast
10.1 Introduction
10.2 Europe Biopharmaceutical Lab Equipment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biopharmaceutical Lab Equipment Market Size Forecast by Type
10.6.1 Pretreatment Type
10.6.2 Reaction Type
10.6.3 Analysis & Test Type
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biopharmaceutical Lab Equipment Market Size Forecast by Applications
10.10.1 Research Institutions
10.10.2 Pharmaceutical Factory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biopharmaceutical Lab Equipment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biopharmaceutical Lab Equipment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biopharmaceutical Lab Equipment Market Size Forecast by Type
11.6.1 Pretreatment Type
11.6.2 Reaction Type
11.6.3 Analysis & Test Type
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biopharmaceutical Lab Equipment Market Size Forecast by Applications
11.10.1 Research Institutions
11.10.2 Pharmaceutical Factory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biopharmaceutical Lab Equipment Analysis and Forecast
12.1 Introduction
12.2 Latin America Biopharmaceutical Lab Equipment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biopharmaceutical Lab Equipment Market Size Forecast by Type
12.6.1 Pretreatment Type
12.6.2 Reaction Type
12.6.3 Analysis & Test Type
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biopharmaceutical Lab Equipment Market Size Forecast by Applications
12.10.1 Research Institutions
12.10.2 Pharmaceutical Factory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biopharmaceutical Lab Equipment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biopharmaceutical Lab Equipment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biopharmaceutical Lab Equipment Market Size Forecast by Type
13.6.1 Pretreatment Type
13.6.2 Reaction Type
13.6.3 Analysis & Test Type
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biopharmaceutical Lab Equipment Market Size Forecast by Applications
13.10.1 Research Institutions
13.10.2 Pharmaceutical Factory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biopharmaceutical Lab Equipment Market: Competitive Dashboard
14.2 Global Biopharmaceutical Lab Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Agilent Technologies
14.3.3 Waters
14.3.4 Danaher
14.3.5 Thermo Fisher Scientific
14.3.6 Bruker
14.3.7 Eppendorf
14.3.8 Millipore
14.3.9 Shimadzu
14.3.10 Brand GmbH
14.3.11 Telstar
